Occudo Quantitative Strategies LP Has $3.19 Million Stake in The Allstate Co. (NYSE:ALL)

Occudo Quantitative Strategies LP lifted its position in shares of The Allstate Co. (NYSE:ALL - Free Report) by 276.1% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 16,556 shares of the insurance provider's stock after acquiring an additional 12,154 shares during the period. Occudo Quantitative Strategies LP's holdings in Allstate were worth $3,192,000 as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. Ameritas Advisory Services LLC lifted its holdings in Allstate by 117.3% in the fourth quarter. Ameritas Advisory Services LLC now owns 4,896 shares of the insurance provider's stock worth $944,000 after purchasing an additional 2,643 shares during the period. Hennessy Advisors Inc. lifted its holdings in Allstate by 6.9% in the 4th quarter. Hennessy Advisors Inc. now owns 58,600 shares of the insurance provider's stock valued at $11,297,000 after acquiring an additional 3,800 shares during the last quarter. Los Angeles Capital Management LLC lifted its holdings in Allstate by 10.5% in the 4th quarter. Los Angeles Capital Management LLC now owns 508,664 shares of the insurance provider's stock valued at $98,065,000 after acquiring an additional 48,382 shares during the last quarter. Artemis Investment Management LLP lifted its holdings in Allstate by 33.3% in the 4th quarter. Artemis Investment Management LLP now owns 401,542 shares of the insurance provider's stock valued at $77,413,000 after acquiring an additional 100,311 shares during the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in Allstate by 56.0% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 186,792 shares of the insurance provider's stock valued at $36,012,000 after acquiring an additional 67,032 shares during the last quarter. Institutional investors own 76.47% of the company's stock.

Allstate Trading Up 1.9%

Shares of Allstate stock traded up $3.86 on Friday, hitting $209.13. 1,110,471 shares of the company's stock traded hands, compared to its average volume of 1,617,479. The Allstate Co. has a one year low of $156.66 and a one year high of $212.91. The stock has a market capitalization of $55.38 billion, a PE ratio of 12.31, a price-to-earnings-growth ratio of 1.01 and a beta of 0.32. The company has a debt-to-equity ratio of 0.42, a current ratio of 0.36 and a quick ratio of 0.40. The firm's 50-day moving average price is $199.48 and its two-hundred day moving average price is $195.69.

Allstate (NYSE:ALL - Get Free Report) last announced its earnings results on Wednesday, April 30th. The insurance provider reported $3.53 earnings per share for the quarter, missing analysts' consensus estimates of $3.98 by ($0.45). Allstate had a return on equity of 28.20% and a net margin of 7.28%. The company had revenue of $14.30 billion during the quarter, compared to analyst estimates of $16.41 billion. During the same period in the previous year, the company posted $5.13 earnings per share. Allstate's revenue for the quarter was up 7.8% on a year-over-year basis. On average, research analysts expect that The Allstate Co. will post 18.74 EPS for the current fiscal year.

Allstate Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, April 1st. Shareholders of record on Monday, March 10th were issued a $1.00 dividend. This is a boost from Allstate's previous quarterly dividend of $0.92. This represents a $4.00 annualized dividend and a yield of 1.91%. The ex-dividend date was Monday, March 10th. Allstate's dividend payout ratio is currently 27.32%.

Allstate announced that its Board of Directors has initiated a stock buyback program on Wednesday, February 26th that authorizes the company to buyback $1.50 billion in shares. This buyback authorization authorizes the insurance provider to repurchase up to 3% of its stock through open market purchases. Stock buyback programs are usually a sign that the company's leadership believes its stock is undervalued.

Analyst Upgrades and Downgrades

ALL has been the subject of a number of research analyst reports. Keefe, Bruyette & Woods upped their price target on shares of Allstate from $228.00 to $235.00 and gave the company an "outperform" rating in a report on Wednesday, May 7th. Evercore ISI lifted their target price on shares of Allstate from $227.00 to $230.00 and gave the company an "outperform" rating in a research note on Thursday, May 1st. Raymond James reissued a "strong-buy" rating and issued a $250.00 price target (up previously from $240.00) on shares of Allstate in a research note on Monday, May 5th. Wells Fargo & Company lowered their target price on shares of Allstate from $200.00 to $197.00 and set an "equal weight" rating on the stock in a research report on Tuesday, May 6th. Finally, Argus upgraded Allstate from a "hold" rating to a "buy" rating in a report on Monday, March 3rd. One research analyst has rated the stock with a sell rating, one has given a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, Allstate currently has an average rating of "Moderate Buy" and an average price target of $225.20.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.